Overview

A Phase II Study of Paclitaxel and Carboplatin in Patients With an Elevated-Risk Cancer of the Uterus

Status:
Terminated
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study us to determine the best treatment for patients with endometrial cancer who are at an elevated risk for recurrence.
Phase:
Phase 2
Details
Lead Sponsor:
University of Alabama at Birmingham
Treatments:
Albumin-Bound Paclitaxel
Carboplatin
Paclitaxel